论文部分内容阅读
肺癌患者的癌因性疲乏与化疗不良反应的相关性
【机 构】
：
汕头大学医学院附属肿瘤医院,药学部 515031 汕头大学医学院附属肿瘤医院,检验科 515031
【出 处】
：
2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会
【发表日期】
：
2014年5期
其他文献
ATM-mediated phosphorylation of Beclin 1 and mitochondrial fission promote DNA damage-induced mitoph
Mitophagy is a mitochondrial recycling process that primarily promotes cell survival,but can also cause cell death in the presence of prolonged injury.It has been suggested a direct relationship exist
会议
DC120, a novel AKT inhibitor, preferentially inhibits nasopharyngeal carcinoma cancer stem-like cell
Side population (SP) cells in human nasopharyngeal carcinoma (NPC) are known to be enriched for cancer stem-like cells (CSLCs) and are the main cause of drug-resistance and tumor metastasis.In this st
会议
Dual PI3K/mTOR(phosphatidylinositol 3-kinase/mammalian target of rapamycin) inhibitors are being evaluated clinically for the treatment of tumors with a hyperactivated PI3K/mTOR pathway.However, unexp
会议
Ubiquitin degradation of ULK1 by ERK1 and GSK-3β cooperatively attenuates mitophagy and promotes tum
The modulation of autophagy is an important component of tumor initiation and progression and ULK1 plays an essential role in macroautophagy and mitophagy.However, the precise regulatory signaling mec
会议
Objective: To explore the role and mechanism of HM910 in cell proliferation on multiple myeloma.Methods: Human multiple myeloma cell lines RPMI-8226, OPM-2, NCI-H929 and U266 were used to perform an M
Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10
Objective: Linsitinib, a novel dual insulin-like growth factor 1 (IGF-1R)/insulin receptor (IR) kinase inhibitor in phase Ⅲ clinical trial, was investigated the reversal of multidrug resistance (MDR)
Cancer cells were transiently protected from chemotherapeutical agent via emergency intercellular tr
Background: Multidrug resistance (MDR) is a major impediment to the overall success of chemotherapy in clinical oncology.Recently, the intercellular transfer of ABCB1 between tumor cells has been prop
Elevated Expression of Plasma Membrane Ca2+ channel Orai1 and Intracellular Ca2+ Oscillations Contri
Objective: Largely due to the fact that most of patients suffering from ESCC are diagnosed at advanced states, the 5-year survival rate is merely 19%, which is the fourth worst among all cancers.Thus,
Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-li
Cancer stem-like cells (CSC) have garnered significant attention as a therapeutic focus, based on evidence they may represent an etiologic root of treatment-resistant cells.Indeed, expression of the m
Lapatinib antagonizes multidrug resistance-associated protein 1 mediated multidrug resistance by inh
Lapatinib, a tyrosine kinase inhibitor (TKI), is used in the treatment of advanced or metastatic breast cancer overexpressing human epidermal receptor 2 (HER2).Lapatinib can modulate the function of A